• / Free eNewsletters & Magazine
  • / My Account

High Risk

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  6. Research
  1. UPDATE: 43% of U.S. homes are at high risk of natural disaster

    UPDATE: 43% of U.S. homes are at high risk of natural disaster

  2. Detecting Derailers: Korn Ferry Institute Study Shows How to Find Warning Signs before High Potentials Go Off Track

    Detecting Derailers: Korn Ferry Institute Study Shows How to Find Warning Signs before High Potentials Go Off Track

  3. A.M. Best Upgrades Ratings of Barents Re Reinsurance Company Inc.

    A.M. Best Upgrades Ratings of Barents Re Reinsurance Company Inc.

  4. US FDA Approves Expanded Indication For BRILINTA To Include Long-Term Use In Patients With A History Of Heart Attack

    US FDA Approves Expanded Indication For BRILINTA To Include Long-Term Use In Patients With A History Of Heart Attack

  5. Abu Dhabi Police Security Support Lauded by Metropolitan Police for Their Distinguished Abilities

    Abu Dhabi Police Security Support Lauded by Metropolitan Police for Their Distinguished Abilities

  6. European Commission Grants Marketing Authorization for Strensiq™ (asfotase alfa) for the Treatment of Patients with Pediatric-Onset Hypophosphatasia (HPP)

    European Commission Grants Marketing Authorization for Strensiq™ (asfotase alfa) for the Treatment of Patients with Pediatric-Onset Hypophosphatasia (HPP)

  7. Surna, Inc. Announces Appointment of Chief Executive Officer

    Surna, Inc. Announces Appointment of Chief Executive Officer

  8. NexPoint Credit Strategies Fund Announces the Regular Monthly Dividend

    NexPoint Credit Strategies Fund Announces the Regular Monthly Dividend

  9. Amerigroup Provides Grant for YMCA Diabetes Prevention Programs in Louisiana

    Amerigroup Provides Grant for YMCA Diabetes Prevention Programs in Louisiana

  10. Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

    Resverlogix Presents New Data at the European Society of Cardiology Congress 2015 on RVX-208 'apabetalone' a Selective BET Inhibitor

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.